相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Kathleen N. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
mTOR up-regulation of SNRPA1 contributes to hepatocellular carcinoma development
Jing Feng et al.
BIOSCIENCE REPORTS (2020)
Newly diagnosed ovarian cancer: Which first-line treatment?
Domenica Lorusso et al.
CANCER TREATMENT REVIEWS (2020)
Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile
Mingjun Zheng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma
Peter G. Rose et al.
OBSTETRICS AND GYNECOLOGY (2019)
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Stephanie Lheureux et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Avelumab alone or in combination with pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in platinum-resistant or refractory epithelial ovarian cancer: Primary and biomarker analysis of the phase III JAVELIN Ovarian 200 trial
E. Pujade-Lauraine et al.
GYNECOLOGIC ONCOLOGY (2019)
Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis
Michael Schulz et al.
FRONTIERS IN IMMUNOLOGY (2019)
PD-L1 detection using 89Zr-atezolizumab immuno-PET in renal cell carcinoma tumorgrafts from a patient with favorable nivolumab response
Joseph Vento et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer A Phase 2 Clinical Trial
Joyce F. Liu et al.
JAMA ONCOLOGY (2019)
Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer
Huiran Yue et al.
BMC CANCER (2019)
Development of a five-gene signature as a novel prognostic marker in ovarian cancer
R. Wang et al.
NEOPLASMA (2019)
TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer
Rosekeila Simoes Nomelini et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
Shetal A. Patel et al.
IMMUNITY (2018)
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
Rudolf Kaaks et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses
Hung-Wei Cheng et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Ovarian Cancer Prevention and Screening
Usha Menon et al.
OBSTETRICS AND GYNECOLOGY (2018)
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Chaobin He et al.
JOURNAL OF CANCER (2018)
Identifying Gene Signature for the Detection of Ovarian Cancer Based on the Achieved Related Genes
Liangliang Wang et al.
GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Drawing Nomograms with R: applications to categorical outcome and survival data
Zhongheng Zhang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2017)
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient
Alejandro Jimenez-Sanchez et al.
CELL (2017)
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma et al.
CELL (2017)
Conservation of immune gene signatures in solid tumors and prognostic implications
Julia Chifman et al.
BMC CANCER (2016)
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
Priti S. Hegde et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
Mingzhu Yin et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
Jonathan E. Rosenberg et al.
LANCET (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Tumor microenvironment: Sanctuary of the devil
Lanlan Hui et al.
CANCER LETTERS (2015)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
Jo Marie Tran Janco et al.
JOURNAL OF IMMUNOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
R. van de Laar et al.
BRITISH JOURNAL OF CANCER (2014)
A prognostic nomogram to predict overall survival in women with recurrent ovarian cancer treated with bevacizumab and chemotherapy
R. A. Previs et al.
GYNECOLOGIC ONCOLOGY (2014)
Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
Silke Reinartz et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Enhancement of antigen-specific CD8 T cell responses by co-delivery of Fc-fused CXCL11
Hong Namkoong et al.
VACCINE (2014)
A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer
C. K. Lee et al.
ANNALS OF ONCOLOGY (2013)
Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends
A. Waldmann et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Dendritic Cells in the Cancer Microenvironment
Yang Ma et al.
JOURNAL OF CANCER (2013)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Hagen Kulbe et al.
CANCER RESEARCH (2012)
A seven-gene prognostic model for platinum-treated ovarian carcinomas
R. Sabatier et al.
BRITISH JOURNAL OF CANCER (2011)
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
C. K. Lee et al.
BRITISH JOURNAL OF CANCER (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Regression shrinkage and selection via the lasso: a retrospective
Robert Tibshirani
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
Ashour Ahmed Ahmed et al.
JOURNAL OF PATHOLOGY (2010)
The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
Martin Koebel et al.
JOURNAL OF PATHOLOGY (2010)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
A Gene Signature Predictive for Outcome in Advanced Ovarian Cancer Identifies a Survival Factor: Microfibril-Associated Glycoprotein 2
Samuel C. Mok et al.
CANCER CELL (2009)
Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis
Robert J. Kurman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
P. de Graeff et al.
BRITISH JOURNAL OF CANCER (2008)
Building Predictive Models in R Using the caret Package
Max Kuhn
JOURNAL OF STATISTICAL SOFTWARE (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
分享论文
